CHEMED (NYSE: CHE) director Ron DeLyons granted 386 shares of stock

Rhea-AI Filing Summary

DeLyons Ron reported acquisition or exercise transactions in this Form 4 filing.

CHEMED CORP director Ron DeLyons received an award of 386 shares of Capital Stock on May 18, 2026. The shares were valued at $440.77 per share for the transaction. This was a grant or award, not an open-market purchase, and increased his direct holdings to 2,052 shares after the transaction.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider DeLyons Ron

Role null

Type	Security	Shares	Price	Value
Grant/Award	Capital Stock	386	$440.77	$170K

Holdings After Transaction: Capital Stock — 2,052 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Stock award size: 386 shares Award price per share: $440.77 per share Shares held after transaction: 2,052 shares

3 metrics

Stock award size 386 shares Capital Stock grant to director Ron DeLyons on May 18, 2026

Award price per share $440.77 per share Transaction price used to value the stock award

Shares held after transaction 2,052 shares Total direct holdings of Ron DeLyons after the award

Key Terms

Capital Stock, Grant, award, or other acquisition, direct ownership, Award of stock

4 terms

Capital Stock financial

"security_title: "Capital Stock""

Capital stock is the total set of shares that represent ownership in a company, including different classes such as common and preferred stock. Think of it as the number and types of slices in a company’s ownership pie: it matters to investors because it determines voting power, entitlement to dividends, and how a company’s value is divided per share, so changes in capital stock can dilute holdings or alter per‑share metrics.

Grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

direct ownership financial

"ownership_type: "direct""

Award of stock financial

"footnote: "Award of stock""

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DeLyons Ron

(Last) (First) (Middle)

2692 MADISON ROAD

SUITE N1-313

(Street)

CINCINNATI OHIO 45208

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CHEMED CORP [ CHE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Capital Stock	05/18/2026		A		386	A(1)	$440.77	2,052	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Award of stock

	Ron DeLyons	05/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did CHEMED CORP (CHE) director Ron DeLyons report?

Director Ron DeLyons reported receiving an award of 386 shares of CHEMED CORP Capital Stock. The transaction is coded as a grant or award acquisition, reflecting compensation rather than an open-market purchase of shares.

At what price was the CHEMED CORP (CHE) stock award to Ron DeLyons valued?

The 386-share stock award to Ron DeLyons was valued at $440.77 per share. This price is the transaction price per share used to report the award’s value in the insider filing for CHEMED CORP.

How many CHEMED CORP (CHE) shares does Ron DeLyons hold after this award?

After the stock award, Ron DeLyons directly holds 2,052 shares of CHEMED CORP Capital Stock. This total includes the newly awarded 386 shares reported in the most recent Form 4 insider transaction.

What does transaction code A mean in the CHEMED CORP (CHE) Form 4 filing?

Transaction code A in the CHEMED CORP Form 4 indicates a grant, award, or other acquisition of stock. For Ron DeLyons, it reflects a compensation-related stock award, not a purchase on the open market.

Is the CHEMED CORP (CHE) insider transaction by Ron DeLyons a buy or a grant?

The transaction for Ron DeLyons is a grant or award, not a buy. The Form 4 classifies it as a grant, award, or other acquisition, and a footnote describes it specifically as an award of stock.